Results 11 to 20 of about 8,272 (223)
Experimental Study and Early Clinical Application Of a Sutureless Aortic Bioprosthesis [PDF]
INTRODUCTION: The conventional aortic valve replacement is the treatment of choice for symptomatic severe aortic stenosis. Transcatheter technique is a viable alternative with promising results for inoperable patients.
Walter J. Gomes +7 more
doaj +2 more sources
Managing Alpha-Gal Allergy in a Case of Bioprosthetic TAVR. [PDF]
Alpha‐gal syndrome (AGS) is an uncommon IgE‐mediated allergy to mammalian‐derived products, caused by sensitization to the oligosaccharide galactose‐α‐1,3‐galactose (alpha‐gal) after tick exposure. Although AGS is best recognized for delayed anaphylaxis following ingestion of red meat, its implications for exposure to mammalian‐derived biomaterials ...
Patel R +5 more
europepmc +2 more sources
Platelet Reduction after Aortic Bioprosthesis Implantation:Results from the PORTRAIT Study [PDF]
: Platelet count reduction (PR) is a common but unclear phenomenon that occurs after aortic bioprosthesis valve implantation (bio-AVR). This study aimed to investigate the occurrence and clinical impact of PR in patients receiving stented, rapid ...
Jiritano, Federica +37 more
core +1 more source
Valve-shaped thrombus underneath an aortic bioprosthesis [PDF]
We describe massive thrombus formation completely occluding an aortic bioprosthesis in a patient with venoarterial extracorporeal membrane oxygenation and apical venting. The thrombus was surgically removed and the patient recovered with no complications.
Cibin G. +4 more
core +1 more source
Clinical experience with the ATS 3f Enable® Sutureless Bioprosthesis [PDF]
The ATS 3f Enable® Bioprosthesis is a self-expanding valve with a tubular design that allows for decreased leaflet stress and preservation of aortic sinuses. We report the midterm results of a prospective, multicenter clinical study evaluating the safety
Thierry Carrel +18 more
core +1 more source
Experience with the Mitroflow aortic bioprosthesis [PDF]
From October 1985 to May 1990, the Mitroflow bovine pericardial valve was placed in the aortic position in 168 patients (97 men, 71 women) with a mean age of 69.7 years. Eighty-nine patients had isolated aortic valve replacement, and 79 had aortic valve replacement and additional procedures.
R A, Moggio +5 more
openaire +2 more sources
Benefits and Pitfalls of the Perceval Sutureless Bioprosthesis [PDF]
Objective: To highlight the main target points covered by clinical studies on the Perceval sutureless valve for surgical aortic valve replacement (SAVR) and raise a point of discussion for further expansion of its use when compared with stented bioprostheses (SB) and transcatheter aortic valve replacement (TAVR).Methods: We reviewed clinical trials and
Aleksander Dokollari +12 more
openaire +3 more sources
Pulsed Cavitational Ultrasound Softening
The authors propose a novel noninvasive therapeutic approach for degenerative calcified bioprosthetic heart valves based on pulsed cavitational ultrasound (PCU) to improve the valvular function by remotely softening calcified stiff cusps. This study aims
Olivier Villemain, MD +9 more
doaj +1 more source
Aortic root replacement with the stentless Freestyle bioprosthesis [PDF]
In this video tutorial, the technical details for the implantation of the Freestyle stentless bioprosthesis are outlined based on the case of a 76-year-old male patient with symptomatic stenosis of a bicuspid aortic valve and aortic root ...
Arabkhani, Bardia +4 more
core +1 more source
Human aortic bioprosthesis [PDF]
We have read with the greatest interest the paper by Wolfgang A. Goetz et al. entitled Truly stentless molded autologous pericardial aortic valve prosthesis with single point attached commissures in a sheep model [1]. We congratulate the authors on their achievements in the development of valve bioprosthesis.
Wilczyński, L., Zembala, M.
openaire +2 more sources

